Ayrton Capital LLC 13D and 13G filings for PharmaCyte Biotech, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-14 3:38 pm Sale | 2023-12-31 | 13G | PharmaCyte Biotech, Inc. PMCB | Ayrton Capital LLC | 956,229 9.900% | -794,483 (-45.38%) | Filing |
| 2023-05-19 5:19 pm Purchase | 2022-12-31 | 13G | PharmaCyte Biotech, Inc. PMCB | Ayrton Capital LLC | 1,750,712 9.990% | 1,750,712 (New Position) | Filing |